Resultats de la cerca - TSANTOULIS, PETROS
- Mostrar 1 - 20 resultats de 21
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
Are common fragile sites merely structural domains or highly organized “functional” units susceptible to oncogenic stress? per Georgakilas, Alexandros G., Tsantoulis, Petros, Kotsinas, Athanassios, Michalopoulos, Ioannis, Townsend, Paul, Gorgoulis, Vassilis G.
Publicat 2014Text -
5
Citizens' views on sharing their health data: the role of competence, reliability and pursuing the common good per Rivas Velarde, Minerva C., Tsantoulis, Petros, Burton-Jeangros, Claudine, Aceti, Monica, Chappuis, Pierre, Hurst-Majno, Samia
Publicat 2021Text -
6
Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with CSMD3 mutation per Terzic, Julie, Seipel, Amanda, Dubuisson, Jean, Tille, Jean-Christophe, Tsantoulis, Petros, Addeo, Alfredo, Labidi-Galy, S.Intidhar
Publicat 2020Text -
7
Structure-based prediction of BRAF mutation classes using machine-learning approaches per Krebs, Fanny S., Britschgi, Christian, Pradervand, Sylvain, Achermann, Rita, Tsantoulis, Petros, Haefliger, Simon, Wicki, Andreas, Michielin, Olivier, Zoete, Vincent
Publicat 2022Text -
8
Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma per Marinari, Eliana, Allard, Mathilde, Gustave, Robin, Widmer, Valérie, Philippin, Géraldine, Merkler, Doron, Tsantoulis, Petros, Dutoit, Valérie, Dietrich, Pierre-Yves
Publicat 2020Text -
9
Clonal Evolution of a High-Grade Pediatric Glioma With Distant Metastatic Spread per Marinari, Eliana, Dutoit, Valerie, Nikolaev, Sergey, Vargas, Maria-Isabel, Schaller, Karl, Lobrinus, Johannes Alexander, Dietrich, Pierre-Yves, Tsantoulis, Petros, Migliorini, Denis
Publicat 2021Text -
10
Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer per Ballestrero, Alberto, Bedognetti, Davide, Ferraioli, Domenico, Franceschelli, Paola, Labidi-Galy, Sana Intidhar, Leo, Elisabetta, Murai, Junko, Pommier, Yves, Tsantoulis, Petros, Vellone, Valerio Gaetano, Zoppoli, Gabriele
Publicat 2017Text -
11
Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss per Frisone, Daniele, Charrier, Melinda, Clement, Sophie, Christinat, Yann, Thouvenin, Laure, Homicsko, Krisztian, Michielin, Olivier, Bodmer, Alexandre, Chappuis, Pierre O., McKee, Thomas A., Tsantoulis, Petros
Publicat 2019Text -
12
Prospective validation in epithelial tumors of a gene expression predictor of liver metastasis derived from uveal melanoma per Tsantoulis, Petros, Delorenzi, Mauro, Bièche, Ivan, Vacher, Sophie, Mariani, Pascale, Cassoux, Nathalie, Houy, Alexandre, Stern, Marc-Henri, Roman-Roman, Sergio, Dietrich, Pierre-Yves, Roth, Arnaud, Cacheux, Wulfran
Publicat 2019Text -
13
Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab per Thouvenin, Laure, Charrier, Mélinda, Clement, Sophie, Christinat, Yann, Tille, Jean-Christophe, Frigeri, Mauro, Homicsko, Krisztian, Michielin, Olivier, Bodmer, Alexandre, Chappuis, Pierre O., McKee, Thomas A., Tsantoulis, Petros
Publicat 2021Text -
14
Simultaneous evaluation of maspin and CXCR4 in patients with breast cancer per Tsoli, Efthimia, Tsantoulis, Petros K, Papalambros, Alexandros, Perunovic, Branko, England, David, Rawlands, David A, Reynolds, Gary M, Vlachodimitropoulos, Dimitrios, Morgan, Susan L, Spiliopoulou, Chara A, Athanasiou, Thanos, Gorgoulis, Vassilis G
Publicat 2007Text -
15
Outcome of patients with nonmetastatic muscle‐invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin‐based chemotherapy and/or radiotherapy: a retrospe... per Bamias, Aristotle, Tsantoulis, Petros, Zilli, Thomas, Papatsoris, Athanasios, Caparrotti, Francesca, Kyratsas, Christos, Tzannis, Kimon, Stravodimos, Kostas, Chrisofos, Michael, Wirth, Gregory J., Skolarikos, Andreas, Mitropoulos, Dionysios, Constantinides, Constantinos A., Deliveliotis, Charalambos, Iselin, Christophe E., Miralbell, Raymond, Dietrich, Pierre‐Yves, Dimopoulos, Meletios A.
Publicat 2016Text -
16
Array comparative genomic hybridization identifies high level of PI3K/Akt/mTOR pathway alterations in anal cancer recurrences per Cacheux, Wulfran, Tsantoulis, Petros, Briaux, Adrien, Vacher, Sophie, Mariani, Pascale, Richard‐Molard, Marion, Buecher, Bruno, Richon, Sophie, Jeannot, Emmanuelle, Lazartigues, Julien, Rouleau, Etienne, Mariani, Odette, El Alam, Elsy, Cros, Jérôme, Roman‐Roman, Sergio, Mitry, Emmanuel, Girard, Elodie, Dangles‐Marie, Virginie, Lièvre, Astrid, Bièche, Ivan
Publicat 2018Text -
17
Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors per Elias, Kevin M., Tsantoulis, Petros, Tille, Jean-Christophe, Vitonis, Allison, Doyle, Leona A., Hornick, Jason L., Kaya, Gurkan, Barnes, Laurent, Cramer, Daniel W, Puppa, Giacomo, Stuckelberger, Sarah, Hooda, Jagmohan, Dietrich, Pierre-Yves, Goggins, Michael, Kerr, Candace L., Birrer, Michael, Hirsch, Michelle S., Drapkin, Ronny, Labidi-Galy, S. Intidhar
Publicat 2018Text -
18
Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection per Cacheux, Wulfran, Rouleau, Etienne, Briaux, Adrien, Tsantoulis, Petros, Mariani, Pascale, Richard-Molard, Marion, Buecher, Bruno, Dangles-Marie, Virginie, Richon, Sophie, Lazartigues, Julien, Jeannot, Emmanuelle, Farkhondeh, Fereshteh, Sastre-Garau, Xavier, de La Rochefordière, Anne, Labib, Alain, Falcou, Marie-Christine, Stevens, Denise, Roth, Arnaud, Roman-Roman, Sergio, Mitry, Emmanuel, Bièche, Ivan, Lièvre, Astrid
Publicat 2016Text -
19
Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesis per Leach, Joshua D. G., Vlahov, Nikola, Tsantoulis, Petros, Ridgway, Rachel A., Flanagan, Dustin J., Gilroy, Kathryn, Sphyris, Nathalie, Vázquez, Ester G., Vincent, David F., Faller, William J., Hodder, Michael C., Raven, Alexander, Fey, Sigrid, Najumudeen, Arafath K., Strathdee, Douglas, Nixon, Colin, Hughes, Mark, Clark, William, Shaw, Robin, van Hooff, Sander R., Huels, David J., Medema, Jan Paul, Barry, Simon T., Frame, Margaret C., Unciti-Broceta, Asier, Leedham, Simon J., Inman, Gareth J., Jackstadt, Rene, Thompson, Barry J., Campbell, Andrew D., Tejpar, Sabine, Sansom, Owen J.
Publicat 2021Text -
20
RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia per Decroocq, Justine, Birsen, Rudy, Montersino, Camille, Chaskar, Prasad, Mano, Jordi, Poulain, Laury, Friedrich, Chloe, Alary, Anne-Sophie, Guermouche, Helene, Sahal, Ambrine, Fouquet, Guillemette, Gotanègre, Mathilde, Simonetta, Federico, Mouche, Sarah, Gestraud, Pierre, Lescure, Auriane, Del Nery, Elaine, Bosc, Claudie, Grenier, Adrien, Mazed, Fetta, Mondesir, Johanna, Chapuis, Nicolas, Ho, Liza, Boughalem, Aicha, Lelorc’h, Marc, Gobeaux, Camille, Fontenay, Michaela, Recher, Christian, Vey, Norbert, Guillé, Arnaud, Birnbaum, Daniel, Hermine, Olivier, Radford-Weiss, Isabelle, Tsantoulis, Petros, Collette, Yves, Castellano, Rémy, Sarry, Jean-Emmanuel, Pasmant, Eric, Bouscary, Didier, Kosmider, Olivier, Tamburini, Jerome
Publicat 2022Text